Lucid Diagnostics Reports Q4 2025 Earnings: Revenue Up 24%, Test Volume Growth at 29%

Lucid Diagnostics reported a 29% increase in test volume for Q4 2025, exceeding their target range, and achieved a milestone by securing a contract with the US Department of Veteran Affairs. However, the company still awaits Medicare coverage and faces challenges with revenue recognition due to reimbursement process stages. Operating expenses increased due to sales and market access staffing investments.